This program is dedicated to providing or improving services that support first responders and emergency workers who are living with, or at risk of, post-traumatic stress injuries (PTSI).

The application period is now open, and the submission deadline is Monday, May 26, 2025, at 11:59 PM (MDT). For more information on the new cycle and to access the application package, please visit our website https://alberta.ca/first-responders-mental-health-grants.aspx.

Norwegian research organisations can apply for funding for partnerships with Brazil, Canada, India, Japan, China, South Africa, South Korea and the USA, to develop outstanding academic environments in Norway through long-term international collaboration, particularly through strong connections between higher education and research cooperation. 

Norwegian research organizations can also apply for funding to establish and further develop partnerships with African countries. 

Under this call, it will not be possible to enter into agreements with Russian partners. 

Furthermore, INTPART will lead to the achievement of the following sub-goals: 

• lasting international partnerships that increase the quality of higher education and research in Norway 
• good links between higher education and research within the framework of the partnerships 
• collaboration with the labour and business sector to increase quality and relevance within the framework of the partnerships, where relevant.

The call supports the establishment and further development of formalised institutional collaboration on research and higher education. The projects that receive funding must be based on an ongoing research project, centre or cluster at Norwegian research organisations. 

In the application, you must show how the international partnership strengthens the ongoing project. Partners and collaborative activities must be justified by needs and opportunities in research and higher education, and you must demonstrate how the activities contribute to academic and institution-specific strategic goals for research and education quality. The scheme is administered jointly by the Research Council of Norway and the Directorate for Higher Education and Skills (HK-dir).

Only approved Norwegian research organisations are eligible to apply.  Institutions interested in participating (including in Canada) must reach out to their Norwegian partners or prospective partners to express interest in the program.

The Forest Sector Investment and Innovation Program (FSIIP) provides funding for strategic investments in the forest sector that:

• improve productivity and innovation
• enhance competitiveness
• support new market access
• provide benefits to Ontario’s broader forest sector
• strengthen regional economies

Collaboration projects

Support is available for Ontario-based projects with at least $3 million in eligible costs undertaken through a collaboration of:

• forest sector for-profit businesses
• not-for-profit research organizations
• forest industry associations
• academia

Eligible collaborations should develop, diversify and transform Ontario’s forest sector through innovation in technology, process and/or products.

A minimum of three partners are required (including at least one Ontario-based for-profit forestry/wood products company).

The Cancer Therapeutics Innovation Pipeline (CTIP) Program was established to capitalize on Ontario’s expertise in cancer biology and drug discovery. Its aim is to create a pipeline of validated cancer targets and First-in-Class (FiC) or Best-in-Class (BiC), novel, selective lead molecules (small molecules or biologics) that will attract partnerships and/or investment for further preclinical and clinical development. To generate a sustainable pipeline, CTIP will support projects that aim to provide increasing evidence of target validation and disease association using data from knowledge bases, functional assays, and drug screening in relevant in vitro and in vivo models of the cancer type of interest.

CTIP funds projects in four stages of preclinical drug discovery and is currently inviting applications for the following three funding streams:

Early Validation (EV) projects:
Deliver robust translational evidence that a Target-of-Interest (TOI) is associated with a specific cancer type(s) based on data from knowledge bases and from studies demonstrating that perturbation of the TOI in relevant cell-based models produces anti-cancer effects sufficient to trigger a drug discovery campaign. At the end of the EV stage, a strategy and approach to interrogate the target must be available.  

Funding available: Up to $150,000 per year for a maximum of two years.

Early Accelerator (EA) projects
Deliver a validated primary assay to enable initial screening of molecules against a defined target. Preliminary evidence of linearity of results between the primary assay and supporting secondary assays under development is also required. At the end of the EA stage, teams must demonstrate the capability and capacity to scale up production of reagents, recombinant proteins, and/or cell systems needed to support the medium-high throughput screening campaigns of the Late Accelerator stage.

Funding available: Up to $150,000 for a maximum of one year.

Late Accelerator (LA) projects
Focus on screening, using validated primary, secondary, and orthogonal assays and deliver confirmed Hit¹ molecules against a defined target supported by evidence of disease association. A confirmed Hit molecule should possess features that support its potential to become a Lead² molecule.

Funding available: Up to $500,000 per year for a maximum of two years.

Cancer Grand Challenges is a global research initiative that is building an elite, interdisciplinary community to tackle cancer’s most complex problems.

Co-founded in 2020 by the two largest funders of cancer research in the world, Cancer Research UK and the National Cancer Institute in the US, it aims to accelerate high-impact research and translate discoveries for public and patient benefit through global team science.